Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, c1995-

Fibrin* ; Thrombosis*/drug therapy; Humans ; Fibrinolytic Agents/pharmacology ; Fibrinolytic Agents/therapeutic use ; Peptide Hydrolases

Cardiovascular diseases represent the main cause of death. A common feature of cardiovascular disease is thrombosis resulting from intravascular accumulation of fibrin. In the last years, several fibrinolytic enzymes have been discovered in many medicinal or edible mushrooms as potential new antithrombotic agents. This study aimed to compare the fibrin(ogen)olytic activity of crude extracts from the fruiting bodies of four cultivated edible mushrooms: Lentinula edodes , Pleurotus ostreatus , Pleurotus eryngii , and Agrocybe aegerita . Fibrin(ogen)olytic activity was assessed by fibrin plate, spectrophotometric assay and electrophoretic analysis (SDS-PAGE and zymography). The highest activity was detected for P. ostreatus followed by P. eryngii , L. edodes and A. aegerita . Results indicated that enzymes exhibited maximum activity at pH 6-7 and 30-40 °C, respectively. Enzyme activity was inhibited by serine and metalloprotease inhibitors. We proposed a new index called the Specific Fibrin(ogen)olytic Index (SFI), which allows specification of the proportion of the total proteolytic capacity due to the fibrin(ogen)olytic activity. These data suggest that the extracts from fruiting bodies or powdered mushrooms can be used as functional ingredients for the development of new functional foods that may act as thrombolytic agents responding, at the same time, to the increasing demand for safe, healthy and sustainable food.

Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Front Mol Biosci. 2021 May 28;8:680397. (PMID: 34124160)
Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74. (PMID: 12436306)
CMAJ. 2007 Aug 14;177(4):347-51. (PMID: 17698822)
Recent Pat Food Nutr Agric. 2019;10(1):3-19. (PMID: 29866029)
Biosci Biotechnol Biochem. 1999 Dec;63(12):2130-6. (PMID: 10664846)
Arch Microbiol. 2022 Jul 19;204(8):503. (PMID: 35852634)
Molecules. 2021 Apr 23;26(9):. (PMID: 33922630)
Int J Med Mushrooms. 2018;20(1):47-59. (PMID: 29604912)
Evid Based Complement Alternat Med. 2005 Sep;2(3):285-99. (PMID: 16136207)
Int J Biol Macromol. 2021 Jan 31;168:631-639. (PMID: 33227332)
J Plant Physiol. 2011 Sep 1;168(13):1517-25. (PMID: 21496945)
J Microbiol Biotechnol. 2014 Feb 28;24(2):245-53. (PMID: 24248089)
Int J Biol Macromol. 2020 Nov 15;163:1498-1517. (PMID: 32781120)
J Proteomics. 2013 May 27;83:1-14. (PMID: 23517719)
Insect Biochem Mol Biol. 2012 Aug;42(8):537-44. (PMID: 22727120)
Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
Circ Res. 2017 Oct 27;121(10):1133-1135. (PMID: 29074533)
Int J Mol Sci. 2022 May 28;23(11):. (PMID: 35682744)
Lancet. 2020 Mar 7;395(10226):795-808. (PMID: 31492503)
Int J Med Mushrooms. 2012;14(2):95-134. (PMID: 22506573)
Prep Biochem Biotechnol. 2017 Jul 3;47(6):539-546. (PMID: 27136080)
Molecules. 2015 Oct 27;20(10):19489-525. (PMID: 26516828)
J Agric Food Chem. 2015 Mar 4;63(8):2215-24. (PMID: 25664761)
Arch Biochem Biophys. 1952 Oct;40(2):346-51. (PMID: 12997222)
J Nutr. 2014 Jul;144(7):1128S-36S. (PMID: 24812070)
Mar Drugs. 2019 Mar 13;17(3):. (PMID: 30871149)
Biosci Biotechnol Biochem. 2001 Feb;65(2):356-62. (PMID: 11302169)
Bioresour Technol. 2010 Aug;101(16):6475-81. (PMID: 20413306)
Acta Pharmacol Sin. 2005 Dec;26(12):1474-8. (PMID: 16297346)

Keywords: cultivation; edible mushrooms; enzymes; fibrin; fibrin(ogen)olytic activity; fibrinogen

9001-31-4 (Fibrin)
0 (Fibrinolytic Agents)
EC 3.4.- (Peptide Hydrolases)

Date Created: 20221211 Date Completed: 20221216 Latest Revision: 20221221

20231215

PMC9738689

10.3390/molecules27238145

36500238